Viatris Inc. (VTRS) — Stock Valuation & Research

Viatris Inc. operates as a global pharmaceutical and healthcare enterprise. Its business is structured across four primary geographic divisions: Developed Markets, Greater China, JANZ (Japan, Australia, New Zealand), and Emerging Markets. The company offers a comprehensive range of pharmaceutical products, encompassing branded prescription medications, generic and complex generic drugs, biosimilar treatments, and active pharmaceutical ingredients (APIs). These offerings target diverse therapeutic areas, addressing both noncommunicable and infectious diseases. Its biosimilars specifically focus…

VTRS key statistics

Price$16.99
Market cap$19.79B
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeNASDAQ
52-week range9.43-18.39
Dividend (TTM)$0.48 per share
Beta0.88

Explore VTRS's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.